"We have very recently been approached by a number
Post# of 30028
Posted On: 01/28/2015 8:48:46 PM
"We have very recently been approached by a number of leading investment banks to evaluate strategic options for the diagnostics business unit, and are now evaluating the options in this area."
Looks like the 3 conferences in the last two weeks has gained a lot of attention and has introduced some new options to consider:
- Eighth Annual OneMedForum Conference
- Biotech Showcase 2015 Conference
- Noble Financial Capital Markets' Eleventh Annual Investor Conference
"We would also enable current shareholders to participate directly in our soon-to-be revenue generating diagnostics business via a stock dividend, while also maintaining an equity position in our therapeutics and discovery business units. We believe this could unlock some of the significant value inherent in our equity by providing a direct return on investment (ROI) to our long-term shareholders who have remained loyal to the company as we have assembled this tremendous portfolio in areas of significant growth potential in the years ahead."
Interesting choice of words. Do flippers get left out in the cold? Would they be asking themselves why they flipped for X when they could have held for Y?
"We continue to face many challenges as the company grows, and are now preparing to achieve key milestones in our therapeutics business in the weeks and months ahead that will start to show the true value of the pipeline."
A little sooner than I thought, but not complaining.
"Our therapeutics programs are all advancing to key value inflection milestones, and we intend to provide a comprehensive corporate update in the weeks ahead to rationalize the Amarantus value proposition for institutional investors who have been showing increasing interest in the fundamental story. We truly believe 2015 will be a monumental year for Amarantus."
Repeated point of mentioning upcoming milestones and value. I get the feeling this blog was not just geared toward shareholders but to any anyone that is interested in taking a stake. Better do it now, or miss out as offers are on the table.
Looks like the 3 conferences in the last two weeks has gained a lot of attention and has introduced some new options to consider:
- Eighth Annual OneMedForum Conference
- Biotech Showcase 2015 Conference
- Noble Financial Capital Markets' Eleventh Annual Investor Conference
"We would also enable current shareholders to participate directly in our soon-to-be revenue generating diagnostics business via a stock dividend, while also maintaining an equity position in our therapeutics and discovery business units. We believe this could unlock some of the significant value inherent in our equity by providing a direct return on investment (ROI) to our long-term shareholders who have remained loyal to the company as we have assembled this tremendous portfolio in areas of significant growth potential in the years ahead."
Interesting choice of words. Do flippers get left out in the cold? Would they be asking themselves why they flipped for X when they could have held for Y?
"We continue to face many challenges as the company grows, and are now preparing to achieve key milestones in our therapeutics business in the weeks and months ahead that will start to show the true value of the pipeline."
A little sooner than I thought, but not complaining.
"Our therapeutics programs are all advancing to key value inflection milestones, and we intend to provide a comprehensive corporate update in the weeks ahead to rationalize the Amarantus value proposition for institutional investors who have been showing increasing interest in the fundamental story. We truly believe 2015 will be a monumental year for Amarantus."
Repeated point of mentioning upcoming milestones and value. I get the feeling this blog was not just geared toward shareholders but to any anyone that is interested in taking a stake. Better do it now, or miss out as offers are on the table.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼